Literature DB >> 9780007

Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein.

S C Kaul1, E L Duncan, A Englezou, S Takano, R R Reddel, Y Mitsui, R Wadhwa.   

Abstract

The murine mortalin genes, mot-1 and mot-2, are members of the hsp70 family of proteins and differ from each other by only two amino acid residues. Mot-1 is expressed in normal cells and has pancytosolic cellular distribution whereas mot-2 is found in the perinuclear region of immortal cells. We report here that a high level of expression of mot-2 protein resulted in malignant transformation of cells as analysed by anchorage independent growth and nude mice assays. A high level of protein expression is attributed to the 900 bp 3' untranslated region of the cDNA which does not have any transforming activity per se. Mortalin cDNA clones isolated from human transformed cells were also found to have transforming activity in similar assays and a high level of expression was apparent in some of the human immortalized cells that showed non-pancytosolic mortalin immunofluorescence. Taken together, the data suggest that nonpancytosolic mortalin may have a role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780007     DOI: 10.1038/sj.onc.1202017

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  An N-terminal region of mot-2 binds to p53 in vitro.

Authors:  S C Kaul; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 2.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94.

Authors:  S Takano; R Wadhwa; Y Mitsui; S C Kaul
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Mortalin is a prognostic factor of gastric cancer with normal p53 function.

Authors:  Koji Ando; Eiji Oki; Yan Zhao; Ayae Ikawa-Yoshida; Hiroyuki Kitao; Hiroshi Saeki; Yasue Kimura; Satoshi Ida; Masaru Morita; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

Review 5.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

6.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

Review 7.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

Review 8.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review.

Authors:  K Helmbrecht; E Zeise; L Rensing
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

9.  Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes.

Authors:  Renu Wadhwa; Hiroshi Ando; Hiroaki Kawasaki; Kazunari Taira; Sunil C Kaul
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 10.  Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

Authors:  Sarah Jesse; Petra Steinacker; Stefan Lehnert; Frank Gillardon; Bastian Hengerer; Markus Otto
Journal:  CNS Neurosci Ther       Date:  2009-03-09       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.